Fidelity Investments
FPRX

Fidelity Investments’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Fidelity Investments’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-864,288
Closed -$14.7M – 4768
2020
Q4 		$14.7M Buy
864,288
+863,888
+215,972% +$10.8M ﹤0.01% 1835
2020
Q3 		$2K Buy
+400
New +$2.03K ﹤0.01% 3515
2020
Q2 		– Sell
-1,250
Closed -$3K – 4393
2020
Q1 		$3K Buy
1,250
+750
+150% +$3.18K ﹤0.01% 3373
2019
Q4 		$2K Sell
500
-301,512
-100% -$1.19M ﹤0.01% 3612
2019
Q3 		$1.17M Sell
302,012
-1,506,672
-83% -$8.27M ﹤0.01% 2397
2019
Q2 		$10.9M Sell
1,808,684
-1,890,384
-51% -$18.1M ﹤0.01% 1850
2019
Q1 		$49.6M Sell
3,699,068
-8,700
-0.2% -$99.2K 0.01% 1216
2018
Q4 		$34.5M Sell
3,707,768
-328,545
-8% -$3.91M ﹤0.01% 1322
2018
Q3 		$56.2M Sell
4,036,313
-1,245,050
-24% -$18.5M 0.01% 1215
2018
Q2 		$83.5M Buy
5,281,363
+52,319
+1% +$913K 0.01% 1034
2018
Q1 		$89.8M Buy
5,229,044
+889,538
+20% +$17.4M 0.01% 1032
2017
Q4 		$95.1M Buy
4,339,506
+4,240
+0.1% +$136K 0.01% 1017
2017
Q3 		$177M Buy
4,335,266
+17,447
+0.4% +$548K 0.02% 728
2017
Q2 		$130M Sell
4,317,819
-25,682
-0.6% -$802K 0.02% 856
2017
Q1 		$157M Buy
4,343,501
+77,381
+2% +$3.41M 0.02% 799
2016
Q4 		$214M Buy
4,266,120
+14,642
+0.3% +$769K 0.03% 637
2016
Q3 		$223M Buy
4,251,478
+1,434,270
+51% +$68.5M 0.03% 619
2016
Q2 		$116M Buy
2,817,208
+547,808
+24% +$23.8M 0.02% 907
2016
Q1 		$92.2M Buy
+2,269,400
New +$78M 0.01% 999

Other funds holding FPRX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Fidelity Investments's FPRX Position: Q1 2021 in Review

Fidelity Investments sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2021, closing a stake of 864,288 shares — an estimated $14.7M sold.

Fidelity Investments first reported a position in FPRX in Q1 2016 and held it in 19 quarters. The position peaked at $223M in Q3 2016. 147 funds tracked by Wall St. Rank hold FPRX as of Q1 2021.

  • Fidelity Investments reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
  • Fidelity Investments sold 864,288 Five Prime Therapeutics, Inc. shares in Q1 2021, an estimated $14.7M.
  • Fidelity Investments first reported a position in Five Prime Therapeutics, Inc. in Q1 2016 and held it in 19 quarters.
  • Fidelity Investments's Five Prime Therapeutics, Inc. position peaked at $223M in Q3 2016.
  • 147 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2021.

Based on Fidelity Investments's 13F filing for Q1 2021, filed 14 May 2021.